Stay up to date with our newsletter

Get in touch!

What can we do to help?

I would like to:

Lets start the conversation!

Sign up to our newsletter

View open positions on our Careers page,
or connect with us on Linkedin Twitter Facebook Youtube

Thank you!
We will be in touch shortly.

2019.09.20

Sai Life Sciences turns 20!

20 years of Sai Life Sciences

For a company that started in a small laboratory with two fume hoods, Sai Life Sciences has come a long way in its quest of bringing new medicines to life. Over the past two decades, the company has enabled several innovator pharma and biotech customers discover, develop and manufacture innovative new medicines, and make the lives of patients better.

Today, Sai Life Sciences is among the fastest growing CDMOs in India. Backed by committed investors TPG Capital and HBM Partners, the company is making significant investments in augmenting its capabilities to address the growing demand from innovator companies globally. The next 20 years promise to be even more exciting!

News

2020.11.20

Sai Life Sciences opens representative office in Tokyo, Japan

Sai Life Sciences opens representative office in Tokyo, Japan

Sai Life Sciences, one of India’s fastest growing Contract Research, Development & Manufacturing Organizations (CRO-CDMO), announced the opening of its representative office in Tokyo, Japan. The new office will serve as base for the company’s outreach to innovator pharmaceutical and biotech companies in Japan and other countries in the Asia Pacific region. A seasoned industry […]
Read more

2020.10.26

Biology, DMPKT & Vivarium

Sai Life Sciences to significantly expand biology capabilities at its integrated R&D campus

Commences construction of new 75,000 sq. ft. facility in Hyderabad Augmenting India team to 170 biologists Sai Life Sciences, one of India’s fastest growing Contract Research, Development & Manufacturing Organizations (CRDMO), today announced plans to significantly expand its biology capabilities at its integrated R&D campus in Hyderabad, India with a dedicated 75,000 sq. ft. facility […]
Read more

2020.10.23

Green Chemistry Awards

Sai Life Sciences introduces Green Chemistry Awards

With the purpose of celebrating and recognizing teams and projects that demonstrate notable work in Green Chemistry, Sai Life Sciences instituted the ‘Green Chemistry Awards’ earlier this year. Using an internally developed computational model, projects were assessed on their ‘Greenness Index’ that is a composite of several attributes across atom & mass efficiency, e-factor, water […]
Read more

2020.10.23

ICH-M7 Services

Comprehensive ICH-M7 assessments for starting materials, intermediates, and final API

Sai Life Sciences offers comprehensive ICH-M7 services to help assess the potential risks of our customers’ starting materials, intermediates, and final API for mutagenicity assessment. As mandated in the ICH M7 guidelines, pharmaceutical companies are now required to assess, identify, and categorize their starting materials, intermediates and final API routes of synthesis and resulting impurities […]
Read more

2020.09.10

Discovery Biology Laboratory in Cambridge, MA, USA

Sai Life Sciences expands suite of cellular analysis platforms in Cambridge, MA

Sai Life Sciences today announced the addition of state-of-the-art cellular analysis platforms at its Discovery Biology facility in Cambridge, Massachusetts, USA. Coinciding with its first anniversary in Cambridge, the expanded suite of capabilities include the Opera Phenix high content screening platform, FACSCelesta flow cytometer and FACSMelody flow sorter, enabling it to better serve start-up and […]
Read more